Biological Psychiatry · 2016 · 111 citations · 55 references
Life SciencesNeurosciencePharmacologyMolecular NeuroscienceNeuropharmacologySynaptic PlasticityBlood-brain Barrier PharmacologyNeurodegenerative DiseasesNeurodegenerative DisordersNeuroprotectionNeurotransmissionSynaptic TransmissionDendritic Spine FunctionDendritic Spine LossDendritic Spine MorphologyDendritic SpinesElectrophysiological RecordingsSpine Density RegulationSynaptic Plasticity DisruptionTherapeutic Targeting Of Amyloid
55
Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP
Guoping Feng, Rebecca H. Mellor, M. Bernstein et al. · Neuron · 2000 · 3.1K citations · Full text
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3.1K citations
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 2K citations · Full text
Medicine, Neurology, Pharmacology +17
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text
Medicine, Neurology, Neuroscience +14